Erik Erik Erik

Morning Brew August 5 2022

Morning Brew 1 minute to read
Erik
Erik Schafhauser

Senior Relationship Manager

Summary:  FOMC key


 Good Morning,

Yesterday markets seesawed and closed little changed in the end all 3 US Indexed ended less than 0.5% from Wednesdays close. The German Benchmark attempted to break higher yesterday but gave up most gains after closing the technical gap and the BoE warning of recession risks. Coinbase and Blackrock announced a cooperation and Coinbase shares can jump by 10%.

As expected, the Bank of England hiked 50 Basis points. A bit surprisingly it expects a recession.

The USD Index fell yesterday as the number of unemployed rose last week in the US, the index fell to 105.93, EURUSD 1.0225, GBPUSD at 1.2135 and USDJPY is 133.35. Gold and Silver trade 1790 and 20.20 -despite weak oil, Bitcoin remains near 23k but a little above.

Today, unless something really extraordinary happens, all eyes will be on the US Labor market and the Non-Farm Payroll at 14:30.. Economists expect 250,000 jobs added in July, the unemployment rate at 3.6% and the average earnings at 0.3%.  Todays data points will be a part of the Feds next rate decision so extremely important.

Peter Garnry published an article on the biotech sector yesterday and Kim Cramer took the opportunity to take a look at the sector from the technical side. Both are very much worth a look. Among the ETF, the  iShares Healthcare Innovation ETF and the iShares Healthcare Innovation ETF have issued a KID and are available for retail clients as well.

Peters article is here: Cutting Edge Biotech

Kim`s is here: NextGen Medicine ETF's 

It seems we are observing the classic investment cycle where may are not participating in the recovery, the US 500 has recovered 15% off the June lows  Investors continue to buy equities in the Fed-meeting break, the next meeting is end of September. Good earnings and strong fundamental data helps, risks seem to be widely ignored by the broader market.

Technically as well as fundamentally the best  course of action seems to be cautiously optimistic, stops or protection are nevertheless a good idea.

 

 

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)
Full disclaimer (https://www.home.saxo/legal/saxoselect-disclaimer/disclaimer)

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900
Hellerup
Denmark

Contact Saxo

Select region

International
International

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

This website can be accessed worldwide however the information on the website is related to Saxo Bank A/S and is not specific to any entity of Saxo Bank Group. All clients will directly engage with Saxo Bank A/S and all client agreements will be entered into with Saxo Bank A/S and thus governed by Danish Law.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.